Skip to main content
SpringerLink
Log in

Adalimumab/methotrexate

Lack of efficacy and development of anti-drug antibodies : case report

  • Case report
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Kapoor DM, et al. Erythrodermic psoriasis peculiarly sparing anti-TNF injection sites in a patient with secondary loss of efficacy. Dermatologic Therapy 30: No. 6, Nov-Dec 2017. Available from: URL: http://doi.org/10.1111/dth.12551 - Singapore

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Adalimumab/methotrexate. Reactions Weekly 1724, 18 (2018). https://doi.org/10.1007/s40278-018-52997-5

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-018-52997-5

Search

Navigation